Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: Persisting uncertainties

Nature Clinical Practice Oncology

Volumn 5, Issue 8, 2008, Pages 444-454

  Choueiri, Toni K ^a   Raghavan, Derek ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; MITOMYCIN; PACLITAXEL; VINBLASTINE;

BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CYSTECTOMY; EUROPE; FOLLOW UP; HUMAN; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MUSCLE CANCER; NORTH AMERICA; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TRANSURETHRAL RESECTION; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS AS TOPIC; CYSTECTOMY; DISEASE-FREE SURVIVAL; HUMANS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; URETHRA; URINARY BLADDER NEOPLASMS;

EID: 48649087141     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc1159     Document Type: Review

References (66)

1. Raghavan D (1988) Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer. Br J Urol 61: 1-8
2. Parekh DJ et al. (2006) Superficial and muscle-invasive bladder cancer principles of management for outcomes assessments. J Clin Oncol 24: 5519-5527
3. Raghavan D (2003) Progress in the chemotherapy of metastatic cancer of the urinary tract. Cancer 97: 2050-2055
4. Tannock I et al. (1984) The radiation response of human bladder cancer assessed in vitro or as xenografts in immune-deprived mice. Int J Radiat Oncol Biol Phys 10: 1897-1902
5. Goffinet DR et al. (1975) Bladder cancer results of radiation therapy in 384 patients. Radiology 117: 149-153
6. Goodman GB et al. (1981) Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int J Radiat Oncol Biol Phys 7: 569-573
7. Yu WS et al. (1985) Bladder carcinoma: Experience with radical and preoperative radiotherapy in 421 patients. Cancer 56: 1293-1299
8. Duncan W and Quilty PM (1986) The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7 299-310
9. Jenkins BJ et al. (1988) Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62: 343-346
10. Blandy JP et al. (11988) Radical radiotherapy and salvage cystectomy for T2/3 cancer of the bladder. Prog Clin Biol Res 260: 447-451
11. Greven KM et al. (1990) Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 65: 908-912
12. Davidson SE et al. (1990) Assessment of factors influencing the outcome of radiotherapy for bladder cancer. BrJ Urol 66:288-293
13. Jahnson S et al. (1991) Bladder carcinoma - a 20-year review of radical irradiation therapy. Radiother Oncol 22: 111-117
14. Gospodarowicz MK et al. (1991) Bladder cancer: Long-term follow-up results of patients treated with radical radiation. Clin Oncol (R Coll Radiol) 3: 155-161
15. Smaaland R et al. (1991) Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Br J Urol 67: 61-69
16. Mameghan H et al. (1992) The management of invasive transitional cell carcinoma of the bladder: Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia. Cancer 69: 2771-2778
17. Fossa SD et al. (1993) Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer: A retrospective analysis of 317 patients. Cancer 72: 3036-3043
18. Pollack A et al. (1994) Muscle-invasive bladder cancer treated with external beam radiotherapy: Prognostic factors. Int J Radiat Oncol Biol Phys 30: 267-277
19. Moonen L et al. (1998) Muscle-invasive bladder cancer treated with external beam radiotherapy: Pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment. Radiother Oncol 49: 149-155
20. Borgaonkar S et al. (2002) Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder: Results following the introduction of a CT planning technique. Clin Oncol (R Coll Radiol) 14: 141-147
21. Rödel C et al. (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20: 3061-3071
22. Raghavan D et al. (1997) Biology and management of invasive bladder cancer. In Principles and Practice of Genitourinary Oncology 281-298 vol 27 (Eds. Raghavan D et al.) Philadelphia: Lippincott-Raven)
23. Hayter CR et al. (1999) A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 45: 1239-1245
24. Scrimger RA et al. (2001) Muscle-invasive transitional cell carcinoma of the urinary bladder: A population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys 51 23-30
25. Whitmore WF Jr (1964) Preoperative irradiation combined with cystectomy in the treatment of bladder cancer. Proc Natl Cancer Conf 5: 481-484
26. Whitmore WF (1980) Integrated irradiation and cystectomy for bladder cancer. Br J Urol 52: 1-9
27. Pollack A et al. (1994) Preoperative radiotherapy for muscle-invasive bladder carcinoma: Long term follow-up and prognostic factors for 338 patients. Cancer 74: 2819-2827
28. Miller LS (1977) Bladder cancer: Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer 39: 973-980
29. Bloom HJ et al. (1982) Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 54: 136-151
30. Sell A et al. (1991) Treatment of advanced bladder cancer category T2 T3 and T4a: A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group. Scand J Urol Nephrol Suppl 138: 193-201
31. Shelley MID et al. (2GO4) A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: Are these data relevant to modern practice? Clin Oncol (R Coll Radiol) 16: 166-171
32. Wallmeroth A et al. (1999) Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): An autopsy study on 367 patients. Urol Int 62: 69-75
33. Skipper HE et al. (1965) Experimental evaluation of potential anticancer agents. XIV. Further study of certain basic concepts underlying chemotherapy of leukemia. Cancer Chemother Rep 45 5-28
34. Railo M et al. (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68: 579-583
35. Goldie JH and Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727-1733
36. Kennedy KA (1987) Hypoxic cells as specific drug targets for chemotherapy. Anticancer Drug Des 2: 181-194
37. Basavaraju SIR and Easterly CE (2002) Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 29: 2391-2403
38. Bentzen SM et al. (2007) Exploitable mechanisms for combining drugs with radiation: Concepts, achievements and future directions. Nat Clin Pract Oncol 4: 172-180
39. Brown JM (1985) Sensitizers and protectors in radiotherapy. Cancer 55: 2222-2228
40. Schierl R et al. (1995) Long-term platinum excretion in patients treated with cisplatin. Cancer Chemother Pharmacol 36: 75-78
41. Zietman AL et al. (1993) The combination of cisplatin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. Int J Radiat Oncol Biol Phys 27: 161-170
42. Shipley WU et al. (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258: 931-935
43. Tester W et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 25: 783-790
44. Coppin CM et al. (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14: 2901-2907
45. Chauvet B et al. (1996) Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy. J Urol 156: 1258-1262
46. Kaufman DS et al. (2000) The initial results in muscle-invading bladder cancer of RTOG 95-06: Phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 5: 471-476
47. Hagan MP et al. (2003) RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys 57: 665-672
48. Kaufman DS et al. (2005) Muscle-invading bladder cancer, RTOG Protocol 99-06: Initial report of a phase I/II trial of selective biadder-conservation employing TURBT, accelerated irradiation sensitized with cisplatin and paclitaxel followed by adjuvant cisplatin and gemcitabine chemotherapy [abstract #4506]. J Clin Oncol
49. Gogna NK et al. (2006) Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential phase II studies from the Trans Tasman Radiation Oncology Group. Radiother Oncol 81: 9-17
50. Stein JP et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19: 666-675
51. Raghavan D et al. (1985) Initial intravenous cisplatinum therapy: improved management for invasive high risk bladder cancer? J Urol 133: 399-402
52. Herr HW et al. (1983) Planned preoperative cisplatin and radiation therapy for locally advanced bladder cancer. Cancer 52: 2205-2208
53. Shearer RJ et al. (1988) Adjuvant chemotherapy in T3 carcinoma of the bladder - a prospective trial: Preliminary report. Br J Urol 62: 558-564
54. Wallace DM et al. (1991) Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 67: 608-615
55. International Collaboration of Trialists (1999) Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial. Lancet 354: 533-540
56. Sengelov L et al. (2002) Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours. Acta Oncol 41: 447-456
57. Advanced Bladder Cancer Overview Collaboration. Neoadjuvant chemotherapy for invasive bladder cancer. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD005246. doi:10.1002/14651858.CD005246.
58. Advanced Bladder Cancer Meta-analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis. Lancet 361: 1927-1934
59. Winquist E et al. (2004) Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis. J Urol 171: 561-569
60. Grossman HB et al. (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349: 859-866
61. Tester W et al. (1996) Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: Results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 14: 119-126
62. Kaufman DS et al. (1993) Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 329: 1377-1382
63. Shipley WU et al. (1998) Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16: 3576-3583
64. James N and Hussain SA (2005) Management of muscle invasive bladder cancer - British approaches to organ conservation. Semin Radiat Oncol 15: 19-27
65. Herr HW et al. (1998) Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: Ten-year outcome. J Clin Oncol 16: 1298-1301
66. James N and Hussain SA (2005) Management of muscle invasive bladder cancer - British approaches to organ conservation. Semin Radiat Oncol 15: 19-27.